Objective: The efficacy and tolerability of acarbose were examined in a postmarketing surveillance study of 27,803 patients with diabetes mellitus ... of a new drug. On the other hand, a ...

As expected, type 1 patients were younger, had a lower mean body mass index, and had a longer mean diabetes duration ... concomitant medication was received by 81% of acarbose and 86% of placebo ...

If you've recently received a diagnosis of type 2 diabetes, understanding your treatment options is an important first step.

A specific type of diabetes medication has been associated with a lower risk of dementia, Alzheimer's and Parkinson's disease in a study published today. The South Korean study followed 358,862 ...

Share on Pinterest A new study found that certain diabetes medications could help lower the risk of neurodegenerative diseases. FG Trade/Getty Images A team of scientists in Korea recently ...

Synex Medical just raised $21.8 million to build a portable MRI capable of testing glucose and other important molecules ...

A recent study has revealed that certain medications used to treat type 2 diabetes may offer protection against dementia and Alzheimer’s disease (AD). The research, published in the American ...

The data includes approximately 300,000 adults aged 18–84 who started treatment with either GLP-1 analogs or SGLT2 inhibitors, another type of diabetes medication, during the years 2013–2021.

Canadian researchers say the type 2 diabetes drug metformin could help to reduce the viral reservoir — or even clear it out completely — in people living with human immunodeficiency virus (HIV ...

Metformin is stirring hope as a potential anti-ageing wonder drug, but it is officially sanctioned only for battling type 2 diabetes. Metformin is not a new drug, but recently there’s been quite ...

Though Habener didn't realize its significance at the time, this turned out to be the fish-equivalent of "GLP-1," the foundation for today's diabetes and obesity drugs. "That's what's beautiful ...